INFI - インフィニティ・ファ―マシュ―ティカルズ (Infinity Pharmaceuticals Inc.) インフィニティ・ファ―マシュ―ティカルズ

 INFIのチャート


 INFIの企業情報

symbol INFI
会社名 Infinity Pharmaceuticals Inc (インフィニティ・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 インフィニティ・ファーマシューティカルズ(Infinity Pharmaceuticals Inc.)は創薬・新薬開発会社。同社の主力製品は同社が血液悪性腫瘍と炎症性疾患において研究しているクラスI ・PI3K- デルタとPI3K- ガンマの強力な経口阻害剤である。同社のretaspimycin塩酸塩(HCl)は熱ショック蛋白質90(Hsp90)の強力な選択的阻害剤である。ホスホイノシチド3 - キナーゼ(PI3K)は中心ノードとして細胞表面受容体から下流の生化学的事象へ信号を伝達する重要な細胞信号伝達蛋白質である。同社のこのプログラムにおける主力開発候補は臨床試験が行われた、血液悪性腫瘍と炎症性疾患を形成するクラスI PI3K-デルタ・ガンマの強力な経口阻害剤IPI-145である。血液悪性腫瘍は血液・骨髄の癌であり、慢性リンパ性白血病(CLL)、ホジキンリンパ腫、非ホジキンリンパ腫(NHL)などの白血病とリンパ腫を含む。   インフィニティ・ファ―マシュ―ティカルズは、米国のバイオ医薬品企業。主力製品候補のIPI-145は血液悪性腫瘍と炎症性疾患を対象とする、ホスホイノシチド3-キナ―ゼ(PI3K)のクラスIデルタとガンマアイソフォ―ムの経口阻害剤である。またIPI-443などを参考に、第二のPI3K製品候補、PI3Kデルタとガンマの経口阻害剤を開発。   Infinity Pharmaceuticals, Inc. ('Infinity' or the 'Company'), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies. MARIO-275 is a randomized, controlled combination study of eganelisib combined with Opdivo® in I/O naïve urothelial cancer. MARIO-3 is the first eganelisib combination study in front-line advanced cancer patients and is evaluating eganelisib in combination with Tecentriq® and Abraxane® in front-line TNBC and in combination with Tecentriq and Avastin® in front-line RCC. In collaboration with Arcus Biosciences, Infinity is evaluating a checkpoint inhibitor-free, novel combination regimen of eganelisib plus etrumadenant (AB928, a dual adenosine receptor antagonist) plus Doxil® in advanced TNBC patients. In 2019, Infinity completed enrollment in MARIO-1, a Phase 1/1b study evaluating eganelisib as a monotherapy and in combination with Opdivo (nivolumab) in patients with advanced solid tumors including patients refractory to checkpoint inhibitor therapy. With these studies Infinity is evaluating eganelisib in the anti-PD-1 refractory, I/O-naïve, and front-line settings.
本社所在地 784 Memorial Drive Cambridge MA 02139 USA
代表者氏名 Adelene Q. Perkins アデリーンQ.パーキンス
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 617-453-1000
設立年月日 34759
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 22人
url www.infi.com
nasdaq_url https://www.nasdaq.com/symbol/infi
adr_tso
EBITDA EBITDA(百万ドル) -32.06800
終値(lastsale) 2.45
時価総額(marketcap) 139283842.6
時価総額 時価総額(百万ドル) 144.96890
売上高 売上高(百万ドル) 6.00000
企業価値(EV) 企業価値(EV)(百万ドル) 95.80390
当期純利益 当期純利益(百万ドル) 43.64100
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Infinity Pharmaceuticals Inc. revenues was not reported. Net loss decreased 40% to $16.4M. Lower net loss reflects Other expense decrease from $6.9M (expense) to $0K Other General and administrative decrease of 44% to $5.5M (expense) Stock Based compensation in General and decrease of 46% to $1.5M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.54 to -$0.31.

 INFIのテクニカル分析


 INFIのニュース

   Pleasing stocks: Adverum Biotechnologies, Inc. (NASDAQ:ADVM 1.46%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI 3.26%)  2021/10/08 00:42:20 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Pleasing stocks: Adverum Biotechnologies, Inc. (NASDAQ:ADVM 1.46%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI 3.26%) appeared first on Stocks Equity .
   Mesmerizing stocks: PG&E Corporation (NYSE:PCG 0.68%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI -3.51%)  2021/10/02 00:22:13 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Mesmerizing stocks: PG&E Corporation (NYSE:PCG 0.68%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI -3.51%) appeared first on Stocks Equity .
   Seducing stocks: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI -4.31%), Alfi, Inc. (NASDAQ:ALF -2.42%)  2021/09/26 23:20:24 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Seducing stocks: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI -4.31%), Alfi, Inc. (NASDAQ:ALF -2.42%) appeared first on Stocks Equity .
   Holding stocks: Facebook, Inc. (NASDAQ:FB 1.94%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI -3.37%)  2021/09/25 01:23:14 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Holding stocks: Facebook, Inc. (NASDAQ:FB 1.94%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI -3.37%) appeared first on Stocks Equity .
   Honest Ways To pick this stocks: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR 0.81%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI 3.40%)  2021/09/21 23:32:09 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Honest Ways To pick this stocks: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR 0.81%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI 3.40%) appeared first on Stocks Equity .
   Infinity Pharmaceuticals names Robert Ilaria as chief medical officer  2021/09/07 11:59:37 Seeking Alpha
   Infinity Pharmaceuticals Appoints Robert Ilaria, Jr., M.D., as Chief Medical Officer and Brian Schwartz, M.D., to Its Board of Directors  2021/09/07 11:35:00 Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which is designed to address a fundamental biologic mechanism of immune suppression in cancer, today announced the appointment of Robert Ilaria, Jr., M.D. as Chief Medical Officer. In addition, Brian Schwartz, M.D., will be transitioning from his role as Consulting C
   Indicators from Technical Perspective: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI 5.43%), International Tower Hill Mines Ltd. (AMEX:THM 6.76%)  2021/09/02 23:16:35 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Indicators from Technical Perspective: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI 5.43%), International Tower Hill Mines Ltd. (AMEX:THM 6.76%) appeared first on Stocks Equity .
   Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences  2021/09/02 12:35:00 Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, today announced that the Company will participate in Wells Fargos Virtual Healthcare Conference and H.C. Wainwrights 23rd Annual Global Investment Conference being held virtually. Pr
   Make a hit with This stocks: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI -2.68%), Aqua Metals, Inc. (NASDAQ:AQMS 6.22%)  2021/08/30 23:12:13 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Make a hit with This stocks: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI -2.68%), Aqua Metals, Inc. (NASDAQ:AQMS 6.22%) appeared first on Stocks Equity .
   Volume Movers: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Morgan Stanley (NYSE:MS)  2021/07/08 23:13:57 Stock Equity
Infinity Pharmaceuticals, Inc. (INFI) with the stream of -0.54% also noticed, India Morgan Stanley (MS) encountered a rapid change of -1.80% in the last hour of Thursdays trading session. Infinity The post Volume Movers: Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Morgan Stanley (NYSE:MS) appeared first on Stocks Equity .
   Infinity Pharma wins buy rating from B. Riley ahead of key milestone  2021/07/07 15:18:38 Seeking Alpha
   Oscillating Stock- Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) with the Stream of 1.17%  2021/06/10 22:11:32 Stock Equity
On Thursday, Shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) reached at $3.45 price level during last trade its distance from 20 days simple moving average was 10.26%, and its distance from The post Oscillating Stock- Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) with the Stream of 1.17% appeared first on Stocks Equity .
   EFFECT - INFINITY PHARMACEUTICALS, INC. (0001113148) (Filer) - Stocks News Feed  2021/05/24 04:15:27 Stocks News Feed
Accepted 2021-05-24 00:15:27 Documents Experience the magic of compounding interest with collateral-backed P2P lending - Learn More 1 Effectiveness Date 2021-05-21 Registration Form S-3 Document Format Files Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000 INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see Read More »EFFECT INFINITY PHARMACEUTICALS, INC. (0001113148) (Filer)
   Infinity Pharmaceuticals (INFI) Investor Presentation - Slideshow  2021/05/17 18:49:12 Seeking Alpha

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 インフィニティ・ファ―マシュ―ティカルズ INFI Infinity Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)